LAM Therapeutics公司宣布其临床产品的进展，包括FDA对新的白血病药临床试验的批准以及淋巴瘤临床试验取得的进展 康涅狄格州吉尔福德, Dec. 05, 2017 (GLOBE NEWSWIRE) -- LAM Therapeutics（LAM），一家4Catalyzer公司，在临床产品方面取得进展，其用于治疗白血病患者的LAM-003产品获得美国食品和药物管理局（Food and Drug Administration / FDA）的试验性新药（Investigational New Drug  /...

LAM Therapeutics Announces Progress of its Clinical Portfolio with FDA Clearance of New Trial in Leukemia and Advancement of Clinical Trial in Lymphoma GUILFORD, Conn., Nov. 30, 2017 (GLOBE NEWSWIRE) -- LAM Therapeutics (LAM), a 4Catalyzer company, advanced its clinical portfolio with the U.S. Food and Drug Administration (FDA) clearance of LAM’s...